Prognostic factors in patients with hepatocellular carcinoma
Shirabe, K.; Sugimachi, K.; Harimoto, N.; Tsujita, E.; Sugimachi, K.; Rikimaru, T.; Yamashita, Y.; Tanaka, S.; Shimada, M.
Nihon Rinsho. Japanese Journal of Clinical Medicine 59(Suppl 6): 367-372
2001
ISSN/ISBN: 0047-1852 PMID: 11761974 Document Number: 530819
Document emailed within 1 workday
Related Documents
Zhang, L.; Ren, Z.-g.; Gan, Y.-h.; Wang, Y.-h.; Zhang, B.-h.; Chen, Y.; Xie, X.-y.; Ge, N.-l.; Ye, S.-l. 2010: Therapeutic efficacy and prognostic factors of sorafenib treatment in patients with unresectable primary hepatocellular carcinoma Zhonghua Zhong Liu Za Zhi 32(8): 630-633Li, J.; Wang, L.; Cong, N.; Shi, C.; Bu, W.; Song, J.; Chen, H. 2014: Efficacy of Sorafenib for Advanced Hepatocellular Carcinoma and Prognostic Factors Hepato-Gastroenterology 61(132): 954-957
Alvarez, R.; Bañares, R.; Echenagusía, A.; Carneros, J.A.; Santos, L.; Simó, G.; Camúñez, F. 2000: Prognostic factors for survival following transarterial chemoembolization in advanced hepatocellular carcinoma Gastroenterologia y Hepatologia 23(4): 153-158
Nakagawa, M.; Asahina, Y. 2015: Prognostic significance of fibrosis markers in hepatocellular carcinoma among patients with IFN-based therapy Nihon Rinsho. Japanese Journal of Clinical Medicine 73(Suppl 9): 668-673
Tangkijvanich, P.; Janchai, A.; Charuruks, N.; Kullavanijaya, P.; Theamboonlers, A.; Hirsch, P.; Poovorawan, Y. 2000: Clinical associations and prognostic significance of serum anti-p53 antibodies in Thai patients with hepatocellular carcinoma Asian Pacific Journal of Allergy and Immunology 18(4): 237-243
Kawakita, T.; Shiraki, K.; Yamanaka, Y.; Yamaguchi, Y.; Saitou, Y.; Enokimura, N.; Yamamoto, N.; Okano, H.; Sugimoto, K.; Murata, K.; Yamakado, K.; Takeda, K.; Nakano, T. 2003: A new prognostic scoring system involving des-gamma-carboxy prothrombin as a useful marker for predicting prognosis in patients with hepatocellular carcinoma International Journal of Oncology 23(4): 1115-1120
Chang, Y.-s.; Huang, J.-s.; Yen, C.-l.; Wang, C.-h.; Lai, C.-h.; Wu, T.-h.; Lan, Y.-j.; Chang, P.-h.; Yeh, K.-y. 2015: The Charlson Comorbidity Index is an Independent Prognostic Factor for Treatment-Naïve Hepatocellular Carcinoma Patients with Extrahepatic Metastases Hepato-Gastroenterology 62(140): 1011-1015
Ishikawa, M.; Yogita, S.; Miyake, H.; Fukuda, Y.; Harada, M.; Wada, D.; Tashiro, S. 2002: Clarification of risk factors for hepatectomy in patients with hepatocellular carcinoma Hepato-Gastroenterology 49(48): 1625-1631
Akahane, Y. 2001: Hepatocellular carcinoma in patients with parasitic liver disease--Japanese schistosomiasis and hepatocellular carcinoma Nihon Rinsho. Japanese Journal of Clinical Medicine 59(Suppl 6): 474-477
Uzzau, A.; Cattin, F.; Avellini, C.; Isola, M.; Molaro, R.; Pontello, D.; De Anna, D.; Bresadola, F. 2009: Lack of prognostic predictive value of hepatic agobiopsy in a group of patients operated of hepatic resection for hepatocellular carcinoma Annali Italiani di Chirurgia 80(6): 439-444
Kitada, N.; Kanamori, K.; Konishi, A.; Tanaka, S.; Suginoshita, Y.; Inokuma, T.; Hashida, T. 2013: Analysis of factors affecting the duration of treatment with sorafenib in patients with hepatocellular carcinoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(4): 479-482
Yeh, J-Lin.; Peng, Y-Chun.; Tung, C-Fang.; Yang, D-Yu.; Hu, W-Hsiung.; Chow, W-Keung.; Yeh, H-Zen.; Chen, G-Hum. 2003: Clinical significance and prediction factors of gastric varices in patients with hepatocellular carcinoma Hepato-Gastroenterology 50(53): 1603-1608
Chatani, M.; Teshima, T.; Hata, K.; Inoue, T. 1986: Prognostic factors in patients with brain metastases from lung carcinoma Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 162(3): 157-161
Cappelli, C.; Pirola, I.; Braga, M.; De Martino, E.; Morassi, M.Laura.; Gandossi, E.; Mattanza, C.; Balzano, R.; Castellano, M.; Rosei, E.Agabiti. 2006: Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution Annali Italiani di Chirurgia 77(2): 107-113
Torii, A.; Harada, A.; Nonami, T.; Nakao, A.; Takagi, H. 1994: Tumor localization as a prognostic factor in hepatocellular carcinoma Hepato-Gastroenterology 41(1): 16-19
Ebelt, J.; Neid, M.; Tannapfel, A.; Witzigmann, H.; Hauss, J.; Köckerling, F.; Wittekind, C. 2000: Prognostic significance of proliferation markers in hepatocellular carcinoma (HCC) Zentralblatt für Chirurgie 125(7): 597-601
Cincibuch, J.; Neoral, C.ír.; Aujeský, R.é; Srámek, V.; Schneiderka, P.; Studentová, H.; Melichar, B.; Kohoutek, M.; Stráznická, J.; Vrba, R.; Juránová, J.; Flodr, P.; Machácek, J.; Cwiertha, K. 2010: Prognostic factors in patients with esophageal carcinoma treated with chemoradiation: single center experience Hepato-Gastroenterology 57: 102-103
Talic, R.F.; El Faqih, S.R. 1998: Survival and prognostic factors in renal cell carcinoma in Saudi patients: A ten year review Saudi Medical Journal 19(2): 170-173
Watanuki, A.; Ohwada, S.; Fukusato, T.; Makita, F.; Yamada, T.; Kikuchi, A.; Morishita, Y. 2002: Prognostic significance of DNA topoisomerase IIalpha expression in human hepatocellular carcinoma. Anticancer Research 22(2b): 1113-1119
Karolewski, K.; Kojs, Z.; Jakubowicz, J.; Urbański, K.; Reinfuss, M.; Dymek, Pł.; Jóźwik, P. 2005: Prognostic factors in patients with cervical--confined endometrial carcinoma treated with surgery and postoperative radiotherapy Przeglad Lekarski 62(12): 1444-1446